To help ease side effects, we recommend: Eating smaller, slower meals Prioritizing protein and staying well hydrated Avoiding greasy, heavy, or highly processed foods Not lying down immediately after eating Staying at the lowest effective dose for as long as appetite suppression is working If side effects feel intolerable , persistent, or unusual, or if something simply doesnt feel right, please contact your provider right away
Strong clinical adoption, broad regulatory approvals, and substantial patient populations maintain diabetes as the dominant indication within the GLP-1 market
While these medications are FDA-approved for obesity (BMI 30 kg/m or 27 kg/m with weight-related complications) and/or type 2 diabetes, they are not specifically approved for MASLD/MASH treatment
Heres whats happening on the ground: Increased Pressure on 503A Pharmacies: With 503B facilities unable to produce semaglutide in bulk, the burden shifts to 503A pharmacies, which must compound the medication on a per-patient basis
The San Diego company is testing both an injectable and pill form